Skip to Main Content

Paper Details

Zika virus oncolytic activity requires CD8+ T cells and is boosted by immune checkpoint blockade.
JCI Insight
46
2021
CD8, CD8+, CD8+ T, CD8+ T and myeloid cells, CD8+ T cell, CD8+ T cells, GBM, GBM stem cells, Glioblastoma multiforme, ZIKV, Zika, Zika virus, anti-PD-1 antibody, brain tumor, cancer, gliomas, human, immune-sensitized ZIKV strain, mice, patients, tumor
Author NameAffiliation
Arijita JashWashington University School of Medicine
Chao ShanUniversity of Texas Medical Branch
Hideho Okada
Hideho OkadaParker Institute for Cancer Immunotherapy, University of California San Francisco
Jeremy N Rich
Jeremy N Rich
Jeremy N RichUniversity of California School of Medicine
Jeremy N Rich
Jeremy N RichUniversity of California School of Medicine
Jeremy N Rich
Pei-Yong ShiUniversity of Texas Medical Branch
Pei-Yong Shi
Pei-Yong ShiSealy Center for Structural Biology and Molecular Biophysics and Sealy Center for Vaccine Development, University of Texas Medical Branch
Michael S DiamondWashington University School of Medicine
Michael S Diamond
Michael S Diamond
Michael S DiamondThe Andrew M. and Jane M. Bursky Center for Human Immunology & Immunotherapy Programs
Milan G ChhedaWashington University School of Medicine
Milan G ChhedaWashington University School of Medicine
  • 1 - 19

Datasets

Release 1.2